Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 653.00
-5.00 (-0.76%)
At close: Sep 12, 2025
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 128.82 billion as of September 15, 2025. Its market cap has decreased by -4.90% in one year.
Market Cap
128.82B
Enterprise Value
350.18B
Revenue
68.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
653.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 128.82B, an increase of 3,950.14%. That is a compound annual growth rate of 13.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 129.02B | -1.36% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | 524.12B | 60.07% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.02T |
| Celltrion | 37.45T |
| ALTEOGEN | 26.27T |
| Yuhan | 8,902.50B |
| SK Biopharmaceuticals | 8,724.10B |
| Peptron | 7,094.04B |
| PharmaResearch | 6,503.92B |
| ABL Bio | 5,686.72B |